|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.940 EUR | -1.50% |
|
+6.20% | +84.11% |
| 07-09 | THX Pharma secures its financial roadmap | |
| 06-23 | THX Pharma appoints Sophie Jacq Lapointe to its board of directors |
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
| - | - | |||
| Average | ||||
| Weighted average by Cap. |
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- ALTHX Stock
- Consensus THX Pharma
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
















